Description
This product is prepared for LABORATORY RESEARCH USE ONLY and may not be used for other purposes.
What is SLU-PP-332?
SLU-PP-332 is a potent small-molecule research compound known as a selective agonist of Estrogen-Related Receptor Gamma (ERRγ). This nuclear receptor plays a crucial role in regulating mitochondrial biogenesis, oxidative metabolism, and energy homeostasis. SLU-PP-332 is being explored for its impact on endurance, fat metabolism, and cellular energy efficiency—making it a compelling compound in the fields of metabolic, cardiovascular, and performance-related research.
SLU-PP-332 and Mitochondrial Function
Research suggests that SLU-PP-332 enhances mitochondrial function by activating ERRγ, a regulator of oxidative metabolism and mitochondrial gene expression. ERRγ is predominantly expressed in high-energy tissues such as the heart, kidneys, and skeletal muscle. Activation of this pathway may result in improved energy production and metabolic output in research models, offering insight into potential therapeutic strategies for mitochondrial dysfunction and fatigue-related disorders.
SLU-PP-332 and Endurance
SLU-PP-332 is gaining attention in research focused on physical endurance and stamina. Studies in murine models have shown that ERRγ activation may mimic the effects of endurance training by enhancing mitochondrial activity and increasing oxidative muscle fibers. This has led to interest in SLU-PP-332 for exploring how mitochondrial modulation can affect exercise capacity and athletic performance.
SLU-PP-332 and Metabolism
By modulating ERRγ, SLU-PP-332 may influence lipid and glucose metabolism. Research indicates that activating this pathway could improve fatty acid oxidation, enhance insulin sensitivity, and potentially reduce fat accumulation. These effects make SLU-PP-332 a subject of interest in metabolic research, especially related to obesity, diabetes, and non-alcoholic fatty liver disease (NAFLD).
SLU-PP-332 and Cardiovascular Research
Given ERRγ’s significant expression in cardiac tissue, SLU-PP-332 has been explored for its potential cardiovascular benefits. Research suggests that ERRγ activation may support heart muscle energy demands, particularly under stress conditions. In models of cardiac hypertrophy and failure, ERRγ agonists have demonstrated promising protective effects, warranting further investigation.
Product Information Table
| Property | Details |
|---|---|
| Product Name | SLU-PP-332 Capsules |
| Capsule Content | 250mcg per capsule |
| Container Type | HDPE Bottle |
| Presentation | Encapsulated Powder |
| Molecular Formula | C23H22Cl2N2O4 |
| Molecular Weight | 461.34 g/mol |
| CAS Number | 1423715-04-9 |
| Synonyms | SLUPP332, ERRγ Agonist |
| Research Applications | Mitochondrial Function, Endurance, Metabolism, Cardiovascular Health |
| Purity | >99% (HPLC Verified) |
| Storage | Store in a cool, dry place away from sunlight |
| Form | Capsule |
| Research Use Only | Not for human consumption. Laboratory use only. |
Legal Disclaimer
This product is sold strictly for laboratory research purposes and is not intended for human consumption, diagnostic, therapeutic, or veterinary use. It is not a dietary supplement or drug. Use only by qualified professionals or licensed researchers.
Safety Information
- Keep out of reach of children.
- Handle with appropriate protective equipment.
- Consult relevant material safety data and literature prior to use.
- This compound should be used only in controlled laboratory settings.
Educational Notice
All content on this page is for educational and informational purposes only. The statements herein have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. It is the responsibility of the buyer to determine suitability for their intended research purposes.
